People · Operator
Named in public records as an officer, director or promoter · active 2015–2026 · Biotechnology, Other, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Precision Biosciences Inc | — | Biotechnology | Series C | $153.3M | $1.6B | 2015 |
| Akerna Corp. | — | Other | Series B | $48.6M | $218.9M | 2021 |
| MJ Freeway, LLC | — | Other Technology | Series A | $21.5M | $277.4M | 2015 |
| Pirouette Medical Inc. | — | Biotechnology | Series A | $14.0M | $2.5M | 2021 |
MATTHEW KANE at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside MATTHEW KANE on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Roger McNamee | 2 | 4 |
| Jessica Billingsley | 2 | 3 |
| JEFF SMITH | 1 | 17 |
| Arunas Chesonis | 1 | 11 |
| Ben Auspitz | 1 | 9 |
| Robert Adelman | 1 | 5 |
| Shalini Sharp | 1 | 4 |
| Scott Sozio | 1 | 3 |
| Tony Yao | 1 | 3 |
| Joseph Nemmers | 1 | 3 |
| PARINAZ MOTAMEDY | 1 | 3 |
| John Fowle | 1 | 2 |
| Matthew Bigliardi | 1 | 2 |
| David McCullough | 1 | 2 |
| Mark Iwanowski | 1 | 2 |
| Tahira Rehmatullah | 1 | 2 |
| Nina Simosko | 1 | 2 |
| DEREK JANTZ | 1 | 2 |
| Emery Huang | 1 | 1 |
| TODD MELBY | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.